Source: International Congress 2018 – Let’s interact and discuss the hot topics in pulmonary rehabilitation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Patel (Harefield, United Kingdom), C. Nolan (Harefield, United Kingdom), R. Barker (Harefield, United Kingdom), S. Jones (Harefield, United Kingdom), M. Maddocks (London, United Kingdom), P. George (London, United Kingdom), F. Chua (London, United Kingdom), T. Maher (London, United Kingdom), W. Man (Harefield, United Kingdom). Body composition and mortality in idiopathic pulmonary fibrosis (IPF): a prospective cohort study.. 2056

Member's Comments

No comment yet.

Related content which might interest you: Longitudinal observation of idiopathic pulmonary fibrosis (IPF) patients cohort from one center in Poland. Source: International Congress 2019 – Interstitial lung disease registries Year: 2019 Baseline characteristics and survival of patients with idiopathic pulmonary fibrosis (IPF): analysis from the Swedish IPF registry Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020 Idiopathic pulmonary fibrosis (IPF) patients in Poland – preliminary cohort analysis of EMPIRE registry Source: International Congress 2017 – ILDs: clinical aspects Year: 2017 STARMAP: an observational study to assess disease-relevant outcomes using home-monitoring devices in patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019 Gait speed and prognosis in patients with idiopathic pulmonary fibrosis: a prospective cohort study Source: Eur Respir J, 53 (2) 1801186; 10.1183/13993003.01186-2018 Year: 2019 The added value of comorbidities in predicting survival in idiopathic pulmonary fibrosis: a multicentre observational study Source: Eur Respir J, 53 (3) 1801587; 10.1183/13993003.01587-2018 Year: 2019 Final analysis of RECAP, an open-label extension study of pirfenidone in patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2016 – IPF treatment I Year: 2016 Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study Source: Eur Respir J 2012; 40: 101-109 Year: 2012 Predictors of response to pirfenidone treatment in patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2016 – IPF treatment II Year: 2016 Pirfenidone use in a Swedish cohort of patients with pulmonary fibrosis (PF) Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries Year: 2018 A cohort of patients with a progressive fibrosing phenotype of interstitial lung disease (PF-ILD) other than idiopathic pulmonary fibrosis (IPF): the PROGRESS study Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020 Nutritional assessment in patients with idiopathic pulmonary fibrosis: the NUTRIPF study Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 Analysis of lung function and survival in RECAP: An open-label extension study of pirfenidone (PFD) in patients with idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012 Prospective evaluation of cardio-metabolic comorbidities in a cohort of patients with non-cystic fibrosis bronchiectasis. Source: Virtual Congress 2020 – Interesting clinical problems for the respiratory physician Year: 2020 PROOF: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting in Belgium and Luxembourg: Exposure in the interim report of 175 IPF patients Source: International Congress 2016 – IPF clinical Year: 2016 Real-life experience with pirfenidone in idiopathic pulmonary fibrosis (IPF) in a single centre in Italy. A retrospective study. Source: International Congress 2017 – IPF: from the bench to the bedside Year: 2017 Prospective study of body mass index and risk of adult-onset asthma or chronic obstructive pulmonary disease in women Source: Eur Respir J 2001; 18: Suppl. 33, 506s Year: 2001 Occupational risk factors and idiopathic pulmonary fibrosis. A case-control study Source: Annual Congress 2007 - The air we breathe at home and at work Year: 2007 Healthy survivor bias in patients with idiopathic pulmonary fibrosis in clinical registries. Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia Year: 2021 All-cause mortality in an Idiopathic Pulmonary Fibrosis (IPF) cohort: retrospective analysis with cardiac QRISK-2 Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021